669 related articles for article (PubMed ID: 12579310)
41. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
Mäkinen K; Loimas S; Wahlfors J; Alhava E; Jänne J
J Gene Med; 2000; 2(5):361-7. PubMed ID: 11045430
[TBL] [Abstract][Full Text] [Related]
42. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
Yamamoto S; Suzuki S; Hoshino A; Akimoto M; Shimada T
Cancer Gene Ther; 1997; 4(2):91-6. PubMed ID: 9080117
[TBL] [Abstract][Full Text] [Related]
43. Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer.
Miller PW; Sharma S; Stolina M; Chen K; Zhu L; Paul RW; Dubinett SM
Cancer Gene Ther; 1998; 5(6):380-9. PubMed ID: 9917093
[TBL] [Abstract][Full Text] [Related]
44. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
[TBL] [Abstract][Full Text] [Related]
45. [Experimental studies on the characteristics of suicide gene system HSV-tk/GCV and its effect on dendritic cells].
Wang X; Li L; Feng K; Bai L; Pei X
Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):628-31. PubMed ID: 11877036
[TBL] [Abstract][Full Text] [Related]
46. [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium].
Wang B; Weng J
Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):618-22. PubMed ID: 12487913
[TBL] [Abstract][Full Text] [Related]
47. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
[TBL] [Abstract][Full Text] [Related]
48. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.
Matuskova M; Hlubinova K; Pastorakova A; Hunakova L; Altanerova V; Altaner C; Kucerova L
Cancer Lett; 2010 Apr; 290(1):58-67. PubMed ID: 19765892
[TBL] [Abstract][Full Text] [Related]
49. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
Yang J; Liu TJ; Lu Y
Curr Eye Res; 2007 Jan; 32(1):33-42. PubMed ID: 17364733
[TBL] [Abstract][Full Text] [Related]
50. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
[TBL] [Abstract][Full Text] [Related]
51. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
[TBL] [Abstract][Full Text] [Related]
52. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
Konson A; Ben-Kasus T; Mahajna JA; Danon A; Rimon G; Agbaria R
Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
[TBL] [Abstract][Full Text] [Related]
53. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
Hasegawa H; Shimada M; Yonemitsu Y; Utsunomiya T; Gion T; Kaneda Y; Sugimachi K
Cancer Gene Ther; 2001 Apr; 8(4):252-8. PubMed ID: 11393277
[TBL] [Abstract][Full Text] [Related]
54. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic potency of transduction with herpes simplex virus thymidine kinase gene against multidrug resistant mouse leukemia cells.
Takenaga K; Tagawa M; Sakiyama S
Anticancer Res; 1996; 16(2):681-5. PubMed ID: 8687114
[TBL] [Abstract][Full Text] [Related]
56. HIV vector-mediated targeted suicide gene therapy for adult T-cell leukemia.
Miyake K; Inokuchi K; Miyake N; Dan K; Shimada T
Gene Ther; 2007 Dec; 14(23):1662-7. PubMed ID: 17898798
[TBL] [Abstract][Full Text] [Related]
57. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
[TBL] [Abstract][Full Text] [Related]
58. MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.
Schoensiegel F; Paschen A; Sieger S; Eskerski H; Mier W; Rothfels H; Kleinschmidt J; Schadendorf D; Haberkorn U
Cancer Gene Ther; 2004 Jun; 11(6):408-18. PubMed ID: 15118759
[TBL] [Abstract][Full Text] [Related]
59. Suicide gene therapy for human uterine adenocarcinoma cells using herpes simplex virus thymidine kinase.
Kunishige I; Samejima Y; Shiki Y; Moriyama A; Meruelo D; Saji F; Murata Y
Gynecol Oncol; 1999 Jan; 72(1):16-25. PubMed ID: 9889024
[TBL] [Abstract][Full Text] [Related]
60. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
